BECTON, DICKINSON AND COMPANY Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
BECTON, DICKINSON AND COMPANY (BDX) reported Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest of $699.00 million for the 12-month period ending 2014-09-30, per its 8-K filed 2015-03-13.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest · last filed 2015-03-13
- BECTON, DICKINSON AND COMPANY comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-09-30 was -$244.00M, a 155.58% decline year-over-year.
- BECTON, DICKINSON AND COMPANY comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-06-30 was $324.00M, a 35.00% increase year-over-year.
- BECTON, DICKINSON AND COMPANY comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-03-31 was $332.00M, a 51.60% increase year-over-year.
- BECTON, DICKINSON AND COMPANY comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2013-12-31 was $287.00M, a 57.86% decline year-over-year.
- BECTON, DICKINSON AND COMPANY comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2011 was $1.06B, a 14.07% decline from fiscal 2010.
- BECTON, DICKINSON AND COMPANY comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2010 was $1.23B, a 31.60% increase from fiscal 2009.
- BECTON, DICKINSON AND COMPANY comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2009 was $936.45M, a 10.61% decline from fiscal 2008.
- BECTON, DICKINSON AND COMPANY comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2008 was $1.05B.
| Period end | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | -$244.00M derived: 8-K 12 month − 10-Q 9 month · filed 2015-03-13 | $80.00M derived: sum of 2 quarters · filed 2015-03-13 | $412.00M derived: sum of 3 quarters · filed 2015-03-13 | $699.00M 8-K · filed 2015-03-13 | ||||
| 2014-06-30 | $324.00M 10-Q · filed 2014-08-04 | $656.00M derived: sum of 2 quarters · filed 2014-08-04 | $943.00M 10-Q · filed 2014-08-04 | $1.38B derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2014-03-31 | $332.00M 10-Q · filed 2014-05-05 | $619.00M 10-Q · filed 2014-05-05 | $1.06B derived: sum of 3 quarters · filed 2015-03-13 | $1.30B derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-12-31 | $287.00M 10-Q · filed 2014-02-10 | $726.00M derived: sum of 2 quarters · filed 2015-03-13 | $966.00M derived: sum of 3 quarters · filed 2015-03-13 | $1.19B derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-09-30 | $439.00M derived: 8-K 12 month − 10-Q 9 month · filed 2015-03-13 | $679.00M derived: sum of 2 quarters · filed 2015-03-13 | $898.07M derived: sum of 3 quarters · filed 2015-03-13 | $1.58B 8-K · filed 2015-03-13 | ||||
| 2013-06-30 | $240.00M 10-Q · filed 2014-08-04 | $240.47M 10-Q · filed 2013-08-05 | $459.06M derived: sum of 2 quarters · filed 2014-08-04 | $1.14B 10-Q · filed 2014-08-04 | $1.14B 10-Q · filed 2013-08-05 | $1.33B derived: sum of 4 quarters · filed 2015-03-13 | ||
| 2013-03-31 | $219.00M 10-Q · filed 2014-05-05 | $900.00M 10-Q · filed 2014-05-05 | $899.82M 10-Q · filed 2013-05-09 | $1.09B derived: sum of 3 quarters · filed 2015-03-13 | $1.17B derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2012-12-31 | $681.00M 10-Q · filed 2014-02-10 | $680.75M 10-Q · filed 2013-02-07 | $873.77M derived: sum of 2 quarters · filed 2015-03-13 | $948.37M derived: sum of 3 quarters · filed 2015-03-13 | $1.36B derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2012-09-30 | $192.77M derived: 8-K 12 month − 10-Q 9 month · filed 2015-03-13 | $267.37M derived: sum of 2 quarters · filed 2015-03-13 | $677.57M derived: sum of 3 quarters · filed 2015-03-13 | $1.04B 8-K · filed 2015-03-13 | $1.04B 10-K · filed 2012-11-21 | |||
| 2012-06-30 | $74.60M 10-Q · filed 2013-08-05 | $484.80M derived: sum of 2 quarters · filed 2013-08-05 | $845.23M 10-Q · filed 2013-08-05 | $673.71M derived: sum of 4 quarters · filed 2013-11-27 | ||||
| 2012-03-31 | $410.20M 10-Q · filed 2013-05-09 | $770.63M 10-Q · filed 2013-05-09 | $599.11M derived: sum of 3 quarters · filed 2013-11-27 | $1.03B derived: sum of 4 quarters · filed 2013-11-27 | ||||
| 2011-12-31 | $360.43M 10-Q · filed 2013-02-07 | $188.92M derived: sum of 2 quarters · filed 2013-11-27 | $624.19M derived: sum of 3 quarters · filed 2013-11-27 | $1.12B derived: sum of 4 quarters · filed 2013-11-27 | ||||
| 2011-09-30 | -$171.51M derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | $263.76M derived: sum of 2 quarters · filed 2013-11-27 | $762.13M derived: sum of 3 quarters · filed 2013-11-27 | $1.06B 10-K · filed 2013-11-27 | $1.06B 10-K · filed 2011-11-23 | |||
| 2011-06-30 | $435.27M 10-Q · filed 2012-08-06 | $933.64M derived: sum of 2 quarters · filed 2012-08-06 | $1.23B 10-Q · filed 2012-08-06 | $1.77B derived: sum of 4 quarters · filed 2012-11-21 | ||||
| 2011-03-31 | $498.37M 10-Q · filed 2012-05-03 | $795.24M 10-Q · filed 2012-05-03 | $1.33B derived: sum of 3 quarters · filed 2012-11-21 | $1.50B derived: sum of 4 quarters · filed 2012-11-21 | ||||
| 2010-12-31 | $296.87M 10-Q · filed 2012-02-07 | $834.03M derived: sum of 2 quarters · filed 2012-11-21 | $1.00B derived: sum of 3 quarters · filed 2012-11-21 | $1.18B derived: sum of 4 quarters · filed 2012-11-21 | ||||
| 2010-09-30 | $537.16M derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-21 | $705.30M derived: sum of 2 quarters · filed 2012-11-21 | $881.15M derived: sum of 3 quarters · filed 2012-11-21 | $1.23B 10-K · filed 2012-11-21 | ||||
| 2010-06-30 | $168.14M 10-Q · filed 2011-08-02 | $343.99M derived: sum of 2 quarters · filed 2011-08-02 | $695.20M 10-Q · filed 2011-08-02 | $860.06M derived: sum of 4 quarters · filed 2011-11-23 | ||||
| 2010-03-31 | $175.85M 10-Q · filed 2011-05-04 | $527.06M 10-Q · filed 2011-05-04 | $691.92M derived: sum of 3 quarters · filed 2011-11-23 | $1.17B derived: sum of 4 quarters · filed 2011-11-23 | ||||
| 2009-12-31 | $351.21M 10-Q · filed 2011-02-08 | $516.07M derived: sum of 2 quarters · filed 2011-11-23 | $997.27M derived: sum of 3 quarters · filed 2011-11-23 | |||||
| 2009-09-30 | $164.85M derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-23 | $646.06M derived: sum of 2 quarters · filed 2011-11-23 | $936.45M 10-K · filed 2011-11-23 | |||||
| 2009-06-30 | $481.20M 10-Q · filed 2010-08-04 | $771.60M 10-Q · filed 2010-08-04 | ||||||
| 2008-09-30 | $1.05B 10-K · filed 2010-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |